Drug Delivery Options for Riluzole in the Treatment of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the selective degeneration of motor neurons, leading to muscle atrophy, paralysis, and eventual death. Despite extensive research, treatment options remain limited, with riluzole being the first and one o...
Saved in:
| Main Authors: | Jaber Aghajani, Yousef Deljavan, Maryam Haghighatdoust |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Iran University of Medical Sciences
2025-01-01
|
| Series: | Neurology Letters |
| Online Access: | https://www.neurologyletters.com/article_214254_1a6818812c9a525f48318b69a1b974db.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe
by: Albert C. Ludolph, et al.
Published: (2023-12-01) -
Author Correction: The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe
by: Albert C. Ludolph, et al.
Published: (2025-05-01) -
Static transcranial magnetic stimulation does not alter cortical excitability in patients with amyotrophic lateral sclerosis on riluzole
by: Caspar Stephani, et al.
Published: (2024-11-01) -
POSITIVE IMPACT OF RILUZOLE USE AND SWALLOWING REHABILITATION FOR DYSPHAGIA IN AMYOTROPHIC LATERAL SCLEROSIS: A CASE-BASED PERSPECTIVE
by: Şeyma Alkan, et al.
Published: (2025-03-01) -
Functional connectivity–based prediction of global cognition and motor function in riluzole-naive amyotrophic lateral sclerosis patients
by: Luqing Wei, et al.
Published: (2022-02-01)